课题基金 / 基金详情

Targeting Neurons Involved in Chronic Pain Transmission

Targeting Neurons Involved in Chronic Pain Transmission
针对参与慢性疼痛传播的神经元
批准号:
6344012
负责人:
Douglas A Lappi
金额:
$13.35万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-20 至 2002-09-30

项目摘要

项目成果

Douglas A Lappi的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from applicant's abstract): Chronic pain is an enormous problem in the United States: it is estimated that 30 to 100 million people suffer from it. Often, current treatments are ineffective and the population of sufferers is often described as "under-served." According to recent data, chronic pain is transmitted through the Substance P receptor-expressing neurons of the dorsal horn of the spinal cord. Elimination of these neurons terminates transmission of the chronic pain signal in several rat models. However, this method relied on the death of spinal cord neurons. An alternative method that would maintain the integrity of the neuronal system would be to only disrupt the activities of these neurons. This could be achieved by internalizing molecules into Substance P receptor-expressing neurons that interfere with the ability to transmit the chronic pain signal. It is proposed in this Phase I application to demonstrate that an expression system, useful for expressing molecules that can cause this disruption, can be internalized into Substance P receptor-expressing neurons and can express a marker protein, green fluorescent protein. The success of this application could result in the resolution of serious problems that interfere with the treatment of chronic pain. PROPOSED COMMERCIAL APPLICATION: This proposal will result in the development of an expression system for use in internally manipulating cells to disrupt or alter their function. Such a system would have many applications in scientific research, not only in chronic pain, but in any area where scientists seek to alter cell processes. Additionally, an expression system that can diminish rather than destroy a cell's function would have great possibility in the treatment of disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enhancing CRISPR-based Therapeutic Interventions Via a Targeted Platform Tool
  • 批准号:
    9253170
  • 项目类别:
  • 资助金额:
    $15.0万
  • 财政年份:
    2017
  • 负责人:
    Douglas A Lappi
  • 依托单位:
Development of a Novel Cancer Pain Therapeutic
  • 批准号:
    7928286
  • 项目类别:
  • 资助金额:
    $300.0万
  • 财政年份:
    2010
  • 负责人:
    Douglas A Lappi
  • 依托单位:
Targeting a Poor Prognosis Marker for Tumor Therapy
  • 批准号:
    7999984
  • 项目类别:
  • 资助金额:
    $15.05万
  • 财政年份:
    2010
  • 负责人:
    Douglas A Lappi
  • 依托单位:
Selective Activation in Specific Neuronal Populations
  • 批准号:
    7538504
  • 项目类别:
  • 资助金额:
    $9.92万
  • 财政年份:
    2009
  • 负责人:
    Douglas A Lappi
  • 依托单位: